ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TMDX TransMedics Group Inc

80.345
3.15 (4.07%)
Last Updated: 20:36:34
Delayed by 15 minutes
Share Name Share Symbol Market Type
TransMedics Group Inc NASDAQ:TMDX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.15 4.07% 80.345 80.31 80.38 80.89 76.60 77.20 1,171,919 20:36:34

TransMedics to Participate in the Piper Sandler 36th Annual Healthcare Conference

19/11/2024 9:05pm

PR Newswire (US)


TransMedics (NASDAQ:TMDX)
Intraday Stock Chart


Thursday 21 November 2024

Click Here for more TransMedics Charts.

ANDOVER, Mass., Nov. 19, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will participate in a fireside chat at the upcoming Piper Sandler 36th Annual Healthcare Conference at the Lotte New York Palace. The fireside chat will take place on Tuesday, December 3, 2024, at 4:00 p.m. Eastern Time.

(PRNewsfoto/TransMedics, Inc.)

Event: Piper Sandler 36th Annual Healthcare Conference
Date: Tuesday, December 3, 2024
Time: 4:00 p.m. ET

A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com. The Company's standard investor presentation is also available through this link.

About TransMedics Group, Inc. 
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:     
Brian Johnston
332-895-3222
Investors@transmedics.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-piper-sandler-36th-annual-healthcare-conference-302310521.html

SOURCE TransMedics Group, Inc.

Copyright 2024 PR Newswire

1 Year TransMedics Chart

1 Year TransMedics Chart

1 Month TransMedics Chart

1 Month TransMedics Chart